Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health

Water Research

Volumn 76, Issue , 2015, Pages 187-200

  Simazaki, Dai ^a   Kubota, Reiji ^b   Suzuki, Toshinari ^c   Akiba, Michihiro ^a   Nishimura, Tetsuji ^d   Kunikane, Shoichi ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

^d TEIKYO HEISEI UNIVERSITY   (Japan)

Author keywords

Drinking water; Pharmaceutical; Source water; Therapeutic dose; Water treatment

Indexed keywords

ACTIVATED CARBON; AMIDES; AMINES; ANTIVIRAL AGENTS; BIOMOLECULES; DRUG PRODUCTS; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; OZONE WATER TREATMENT; OZONIZATION; PHASE SEPARATION; POTABLE WATER; PURIFICATION; WATER FILTRATION; WATER TREATMENT; WATER TREATMENT PLANTS;

ADVANCED WATER TREATMENT PROCESS; DRINKING WATER PURIFICATION; GRANULAR ACTIVATED CARBON FILTRATION; LIQUID CHROMATOGRAPHY WITH TANDEM MASS SPECTROMETRY (LCMS/MS); RESIDUAL CONCENTRATIONS; SOLID PHASE EXTRACTION CARTRIDGES; SOURCE WATERS; THERAPEUTIC DOSE;

ACTIVATED CARBON TREATMENT;

ACTIVATED CARBON; AMANTADINE; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIPARKINSON AGENT; ANTIVIRUS AGENT; CARBAMAZEPINE; CONTRAST MEDIUM; DICLOFENAC; DRINKING WATER; EPINASTINE; FENOFIBRATE; IBUPROFEN; IOPAMIDOL; OSELTAMIVIR; TRIMETHYLSILYL DERIVATIVE; CHARCOAL; DRUG; OZONE; WATER POLLUTANT;

ANALYTICAL METHOD; CONCENTRATION (COMPOSITION); DRINKING WATER; DRUG; METABOLITE; PUBLIC HEALTH; PURIFICATION; WATER TREATMENT;

ANALYTIC METHOD; ARTICLE; CONCENTRATION (PARAMETERS); DERIVATIZATION; DRINKING WATER PURIFICATION PLANT; FILTRATION; GAS CHROMATOGRAPHY; JAPAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; OZONATION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WATER MANAGEMENT; WATER SAMPLING; WATER TREATMENT; ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; HUMAN; PROCEDURES; RISK ASSESSMENT; WATER POLLUTANT; WATER SUPPLY;

JAPAN;

CHARCOAL; DRINKING WATER; ENVIRONMENTAL MONITORING; FILTRATION; HUMANS; JAPAN; OZONE; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION; WATER SUPPLY;

EID: 84925760865     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2015.02.059     Document Type: Article

References (40)

1. 2 processes. Chemosphere 2003, 50(1):85-95.
2. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ. Sci. Technol. 2009, 43(3):597-603.
3. Buser H.-R., Müller M.D., Theobald N. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ. Sci. Technol. 1998, 32(1):188-192.
4. Buser H.-R., Poiger T., Müller M.D. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ. Sci. Technol. 1998, 32(22):3449-3456.
5. Drinking Water Inspectorate for England and Wales Desk Based Review of Current Knowledge on Pharmaceuticals in Drinking Water and Estimation of Potential Levels 2007, accessed 18.06.14. http://dwi.defra.gov.uk/research/completed-research/reports/dwi70-2-213.pdf.
6. Hirsch R., Ternes T., Haberer K., Kratz K.-L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999, 225:109-118.
7. Hua W., Bennett E.R., Letcher R.J. Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada. Water. Res. 2006, 40:2259-2266.
8. Huber M.M., Canonica S., Park G.-Y., von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 2003, 37(5):1016-1024.
9. Japan Pharmaceutical Information Center iyakuSearch - Pharmaceutical Information Database 2004, accessed 18.06.14. http://database.japic.or.jp/is/top/index.jsp.
10. Japan Water Works Association Water Supply in Japan 2013 2013, accessed 18.06.14. http://www.jwwa.or.jp/jigyou/kaigai_file/2013WaterSupplyInJapan.pdf.
11. Jones O.A.H., Voulvoulis N., Lester J.N. Human pharmaceuticals in the aquatic environment a review. Environ. Technol. (Lett.) 2001, 22(12):1383-1394.
12. Kemper N. Veterinary antibiotics in the aquatic and terrestrial environment. Ecol. Indic. 2008, 8(1):1-13.
13. Kim S.D., Cho J.W., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water. Res. 2007, 41:1013-1021.
14. Kimura K., Toshima S., Amy G., Watanabe Y. Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes. J. Membr. Sci. 2004, 245(1-2):71-78.
15. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36(6):1202-1211.
16. Kümmerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 2001, 45:957-969.
17. Managaki S., Murata A., Takada H., Tuyen B.C., Chiem N.H. Distribution of macrolides, sulfonamides and trimethoprim in tropical waters: ubiquitous occurrence of veterinary antibiotics in the Mekong Delta. Environ. Sci. Technol. 2007, 41:8004-8010.
18. Matsushita T., Sakuma H., Kobayashi N., Matsui Y., Ohno K. Effect of chlorination on toxicities of iodinated X-ray contrast media solutions. Proceedings of IWA Micropol & Ecohazard 2011, 11-13 July 2011, Sydney, Australia 2011.
19. Ministry of Health, Labour and Welfare Domestic Statistical Survey on Trends in Pharmaceutical Production in FY2005 2006, Jiho Inc, Tokyo, Japan.
20. Ministry of Land, Infrastructure and Transportation 'Freshness' of Rivers across the Nation 2005, accessed 18.06.14. http://www.mlit.go.jp/kisha/kisha04/05/051203_2_.html.
21. Mons M.N., Heringa M.B., van Genderen J., Puijker L.M., Brand W., van Leeuwen C.J., Stoks P., van der Hoek J.P., van der Kooij D. Use of the Threshold of Toxicological Concern (TTC) approach for deriving target values for drinking water contaminants. Water. Res. 2013, 47:1666-1678.
22. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water. Res. 2006, 40:3297-3303.
23. Phillips P.J., Smith S.G., Kolpin D.W., Zaugg S.D., Buxton H.T., Furlong E.T., Esposito K., Stinson B. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ. Sci. Technol. 2010, 44(13):4910-4916.
24. Richardson M.L., Bowron J.M. The fate of pharmaceutical chemicals in the aquatic environment. J. Pharm. Pharmacol. 1985, 37(1):1-12.
25. Sadezky A., Löffler D., Schlüsener M., Roig B., Ternes T. Real Situation: Occurrence of the Main Investigated PPs in Water Bodies, Pharmaceuticals in the Environment 2010, 78-84. IWA Publishing, London, UK.
26. Schittko S., Putschew A., Jekel M. Bank filtration: a suitable process for the removal of iodinated X-ray contrast media?. Water. Sci. Technol. 2004, 50(5):261-268.
27. Seitz W., Jiang J.-Q., Weber W.H., Lloyd B.J., Maier M., Maier D. Removal of iodinated X-ray contrast media during drinking water treatment. Environ. Chem. 2006, 3(1):35-39.
28. Simazaki D., Fujiwara J., Manabe S., Matsuda M., Asami M., Kunikane S. Removal of selected pharmaceuticals by chlorination, coagulation-sedimentation and powdered activated carbon treatment. Water. Sci. Technol. 2008, 58(5):1129-1135.
29. Simazaki D., Hiramatsu S., Fujiwara J., Akiba M., Kunikane S. Monitoring priority of residual pharmaceuticals in water sources and drinking water in Japan. J. Water. Env. Tech. 2014, 12(3):277-285.
30. Snyder S.A., Trenholm R.A., Snyder E.M., Bruce G.M., Pleus R.C., Hemming J.D.C. Toxicological Relavance of EDCs and Pharmaceuticals in Drinking Water 2008, 91238. Awwa Research Foundation.
31. Sui Q., Huang J., Deng S., Yu G., Fan Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water. Res. 2010, 44(2):417-426.
32. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water. Res. 1998, 32(11):3245-3260.
33. Ternes T.A., Hirsch R. Occurrence and behavior of x-ray contrast media in sewage facilities and the aquatic environment. Environ. Sci. Technol. 2000, 34(13):2741-2748.
34. Ternes T.A., Kreckel P., Mueller J. Behaviour and occurrence of estrogens in municipal sewage treatment plants - II. Aerobic batch experiments with activated sludge. Sci. Total Environ. 1999, 225(1-2):91-99.
35. Ternes T.A., Meisenheimer M., Mcdowell D., Sacher F., Brauch H.-J., Haist-Gulde B., Preuss G., Wilme U., Zulei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 2002, 36(17):3855-3863.
36. Ternes T.A., Stüber J., Herrmann N., McDowell D., Ried A., Kampmann M., Teiser B. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?. Water. Res. 2003, 37:1976-1982.
37. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005, 39(17):6649-6663.
38. World Health Organization Pharmaceuticals in Drinking-water 2012, accessed 18.06.14. http://www.who.int/water_sanitation_health/publications/2011/pharmaceuticals/en/.
39. Yamamoto H., Nakamura Y., Moriguchi S., Nakamura Y., Honda Y., Tamura I., Hirata Y., Hayashi A., Sekizawa J. Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: laboratory photolysis, biodegradation, and sorption experiments. Water. Res. 2009, 43(2):351-362.
40. Yoon Y., Westerhoff P., Snyder S.A., Wert E.C. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. J. Membr. Sci. 2006, 270:88-100.